NASDAQ:NTLA | Cash Flow Statement | Intellia Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2015-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$106.63M$2.1M
2026-03-31-$96.23M$2.2M-$117.35M$79,000.00$66.31M$33.57M
2025-12-31-$95.79M$2.38M-$69.29M$126,000.00$27.53M$1.98M
2025-09-30-$101.32M$2.4M
2025-06-30-$101.26M$2.5M
2025-03-31-$114.33M$2.5M-$148.93M$735,000.00$94.33M$0.00
2024-12-31-$128.9M$2.57M-$85.2M$981,000.00$151.57M$2.32M
2024-09-30-$135.71M$2.6M
2024-06-30-$146.98M$2.6M
2024-03-31-$107.44M$2.51M-$120.66M$2.51M$5.9M$59.99M
2023-12-31-$132.16M$2.47M-$93.05M$1.52M$45.94M$106.48M
2023-09-30-$122.22M
2023-06-30-$123.68M
2023-03-31-$103.13M$2.05M-$109.33M$3.83M-$122.25M$2.22M
2022-12-31-$113.41M$2.03M-$89.87M$3.91M-$30.15M$505.76M
2022-09-30-$113.23M
2022-06-30-$100.68M
2022-03-31-$146.87M$1.75M-$79.8M$1.43M$47.47M$47.32M
2021-12-31-$81.24M$1.88M-$54.65M$2.87M-$159.12M$2.28M
2021-09-30-$71.64M
2021-06-30-$68.81M
2021-03-31-$46.21M$1.59M-$52.38M$2.41M-$25.54M$58.6M
2020-12-31-$42.19M$1.6M-$40.23M$1.01M-$210.92M$234.09M
2020-09-30-$27.84M
2020-06-30-$32.39M
2020-03-31-$31.81M$1.54M-$38.55M$845,000.00$57.45M$4.86M
2019-12-31-$402.93M$1.57M-$28.66M$2.57M$27.88M$19.56M
2019-09-30-$23.63M
2019-06-30-$25.68M
2019-03-31-$21.94M$1.3M-$21.45M$1.53M$5.7M$4M
2018-12-31-$19.07M$1.23M-$8.54M$1.59M-$256.02M$30.16M
2018-09-30-$22.7M
2018-06-30-$22.22M
2018-03-31-$21.36M$1.01M-$17.77M$1.85M-$1.85M$6.72M
2017-12-31-$23.96M$833,000.00-$21.31M$2.4M-$2.4M$142.12M
2017-09-30-$15.36M
2017-06-30-$15.59M
2017-03-31-$12.63M$660,000.00-$11.4M$4.16M
2016-12-31-$10.56M$405,000.00-$14.41M$3.41M
2016-09-30-$7.48M
2016-06-30-$6.9M
2016-03-31-$6.69M-$9.42M$1.01M
2015-12-31-$5.25M-$5.49M$849,000.00
2015-09-30-$3.02M
2015-06-30-$3.04M
2015-03-31-$1.09M$4.82M$516,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$412.69M$9.77M-$394.74M$1.13M$228.03M$131.49M
2024-12-31-$519.02M$10.29M-$348.88M$5.78M$125.57M$185.75M
2023-12-31-$481.19M$8.98M-$394.09M$13.99M-$31.35M$130.32M
2022-12-31-$474.19M$7.57M-$333.29M$13.56M$160.31M$582.96M
2021-12-31-$267.89M$6.89M-$225.03M$12.76M-$550.78M$736.69M
2020-12-31-$134.23M$6.31M-$49.91M$3.59M-$214.49M$371.78M
2019-12-31-$474.19M$5.59M-$103.24M$6.79M$25.18M$76.43M
2018-12-31-$85.34M$4.46M-$61.26M$6.36M-$260.78M$40.22M
2017-12-31-$67.54M$2.99M-$65.28M$10.09M-$10.09M$142.98M
2016-12-31-$31.63M$1.1M$36.11M$6.17M-$6.17M$167.3M
2015-12-31-$12.4M$328,000.00-$1.76M$2.55M